Newsroom | 5080 results

Sorted by: Latest

Diabetes
-

Corcept Presents Data from MOMENTUM Trial at American College of Cardiology Annual Scientific Session

REDWOOD CITY, Calif.--(BUSINESS WIRE)--Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic and neurologic disorders by modulating the effects of the hormone cortisol, today presented late-breaking data from its MOMENTUM trial examining the prevalence of endogenous hypercortisolism in patients with resistant hypertension at the 2026 American College of Cardiology...
-

Mochi Health and Livelong Women's Health Summit Partner to Advance Women's Metabolic Health

SAN FRANCISCO--(BUSINESS WIRE)--Mochi Health, the telehealth marketplace transforming how patients access affordable, transparent care, announced its participation as a Premiere Sponsor of the Livelong Women's Health Summit, taking place April 17-18 in San Francisco. Founder and CEO Myra Ahmad, M.D will represent the company as a featured speaker and roundtable host. Myra will join a panel of leading physicians for a session titled "The Ozempic Era: What GLP-1 Medications Mean for Women's Metab...
-

Vida Health Redefines Metabolic Care with New Control Framework for Whole-Population Management

SAN FRANCISCO--(BUSINESS WIRE)--Vida Health announced its Metabolic Control Framework, a clinically grounded approach to proactively manage metabolic health....
-

Shreehas Tambe Appointed CEO & Managing Director of Biocon Limited, Effective April 1, 2026

BENGALURU, India--(BUSINESS WIRE)--Biocon Limited (BSE: 532523; NSE: BIOCON) today announced the appointment of Shreehas Tambe as its Chief Executive Officer & Managing Director, effective April 1, 2026, following approvals from the Nomination & Remuneration Committee and the Board of Directors. As the first CEO of the integrated Biocon, he will lead the combined platform spanning biosimilars and generics, strengthening the Company’s ability to operate at scale and compete effectively i...
-

Aledade Partners Achieve Superior Hypertension Control, Outperforming Large Health Systems in New Case Study

BETHESDA, Md.--(BUSINESS WIRE)--Aledade has announced a new case study demonstrating how its primary care network is controlling hypertension and outperforming national averages....
-

Chronilogix Announces Dr. Geoffrey Williams’ Appointment to Advisory Committee, Supporting Expansion into AI-Driven Mental Health Coaching

PALM BEACH GARDENS, Fla.--(BUSINESS WIRE)--Chronilogix, an AI digital health company transforming access, delivery, and cost of chronic care coaching, today announced that Dr. Geoffrey Williams has joined its Advisory Committee. Dr. Williams’ appointment coincides with Chronilogix’s expansion to include a dedicated AI-powered mental health module, further strengthening the company’s mission to deliver affordable, always-available coaching for individuals managing chronic and behavioral health c...
-

Massive Gaps Uncovered for Diabetes Screening in Urgent Care, Research Shows

NASHVILLE, Tenn.--(BUSINESS WIRE)--UCP Merchant Medicine, the leading provider of consulting services and clinical AI technology for Urgent Care, shared data collected with their Intellivisit software revealing significant gaps in diabetes screening among at-risk urgent care patients. The research study, which included nearly 100,000 urgent care patient encounters, revealed that despite diabetes’ growing prevalence, less than 1% of all encounters included a Capillary Blood Glucose (CBG) test, d...
-

New City of Hope and TGen Study Uncovers Mechanism Explaining How Obesity Increases Cancer Risk

LOS ANGELES & PHOENIX--(BUSINESS WIRE)--Scientists at City of Hope® and TGen (part of City of Hope) are the first to explain a major mechanism for why gaining excess weight increases your risk of cancer. City of Hope is one of the largest and most advanced cancer research and treatment organizations in the United States, with its National Medical Center ranked among the nation’s top cancer centers by U.S. News & World Report. The study, published today in Cancer Research, a journal of the A...
-

Imaginostics Receives Siemens Healthineers Letter of Support as Companies Advance Quantitative MRI Dialogue

ORLANDO, Fla.--(BUSINESS WIRE)--Imaginostics, Inc. today announced that it has received a Letter of Support from Siemens Healthineers in connection with ongoing exploratory discussions regarding potential collaboration in quantitative MRI and imaging biomarkers. As part of these discussions, Imaginostics and Siemens Healthineers intend to continue dialogue concerning potential technical and commercial pathways for Imaginostics’ envisioned ImagiView™ and ImagiSight™ offerings and their potential...
-

Welldoc Bridges the Insulin Dosing Gap with New Real-World Evidence

COLUMBIA, Md.--(BUSINESS WIRE)--Welldoc®, a leader in AI-powered cardiometabolic health solutions, today announced new real-world evidence (RWE) demonstrating improved time in range (TIR) through the use of Welldoc’s Continuous Glucose Monitor (CGM)-informed insulin bolus calculator. For the millions of people who use bolus insulin, daily management is a burden. People with insulin-dependent diabetes make numerous, complex health-related decisions every day. When calculating a mealtime dose, in...